Guy T, Créac'hcadec A, Ricordel C, Salé A, Arnouat B, Bizec JL, Langelot M, Lineau C, Marquette D, Martin F, Lederlin M, Jouneau S. High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU.
Eur Respir J 2020;
56:13993003.01154-2020. [PMID:
32859678 PMCID:
PMC7453734 DOI:
10.1183/13993003.01154-2020]
[Citation(s) in RCA: 42] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2020] [Accepted: 07/27/2020] [Indexed: 12/13/2022]
Abstract
The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing coronavirus disease 2019 (COVID-19), now recognised by the World Health Organization as a pandemic, emerged in late 2019 in China [1]. Patients infected with SARS-CoV-2 can develop severe pneumonia and respiratory failure, which often require treatment in intensive care units (ICU) in Western European countries [2]. Oxygen therapy and supportive care are still the main forms of therapy for SARS-CoV-2 pneumonia until suitable anti-infective therapies become available.
SARS-CoV-2 infected patients with nonhypercapnic acute hypoxaemic respiratory failure can benefit from high-flow nasal oxygen outside an ICU. The technique appears to be safe for healthcare workers and could well liberate critical ICU resources.https://bit.ly/2Xq80iu
Collapse